Skip to main content
Log in

A Novel Nomogram for Predicting Early Rebleeding After Endoscopic Treatment of Esophagogastric Variceal Hemorrhage

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Early rebleeding is a significant complication of endoscopic treatment for esophagogastric variceal hemorrhage (EGVH). However, a reliable predictive model is currently lacking.

Aims

To identify risk factors for rebleeding within 6 weeks and establish a nomogram for predicting early rebleeding after endoscopic treatment of EVGH.

Methods

Demographic information, comorbidities, preoperative evaluation, endoscopic features, and laboratory tests were collected from 119 patients who were first endoscopic treatment for EGVH. Independent risk factors for early rebleeding were determined through least absolute shrinkage and selection operator logistic regression. The discrimination, calibration, and clinical utility of the nomogram were assessed and compared with the model for end-stage liver disease (MELD), Child–Pugh, and albumin-bilirubin (ALBI) scores using receiver-operating characteristic (ROC) curves, calibration plots, and decision curve analyses (DCA).

Results

Early rebleeding occurred in 39 patients (32.8%) within 6 weeks after endoscopic treatment. Independent early rebleeding factors included gastric variceal hemorrhage (GVH), concomitant hepatocellular carcinoma (HCC), international normalized ratio (INR), and creatinine. The nomogram demonstrated exceptional calibration and discrimination capability. The area under the curve for the nomogram was 0.758 (95% CI 0.668–0.848), and it was validated at 0.71 through cross-validation and bootstrapping validation. The DCA and ROC curves demonstrated that the nomogram outperformed the MELD, Child–Pugh, and ALBI scores.

Conclusions

Compared with existing prediction scores, the nomogram demonstrated superior discrimination, calibration, and clinical applicability for predicting rebleeding in patients with EGVH after endoscopic treatment. Therefore, it may assist clinicians in the early implementation of aggressive treatment and follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ALBIscore:

Albumin-bilirubin score

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

AUC:

Area under the ROC curve

BROT:

Balloon-occluded retrograde transvenous obliteration

DCA:

Decision curve analysis

EBL:

Endoscopic band ligation

EGVH:

Esophagogastric variceal hemorrhage

EVH:

Esophageal variceal hemorrhage

GOV1:

Type 1 gastroesophageal varices

GOV2:

Type 2 gastroesophageal varices

GVH:

Gastric variceal hemorrhage

HVPG:

Hepatic venous pressure gradient

IGV1:

Type 1 isolated gastric varices

INR:

International normalized ratio

IQR:

Interquartile range

LASSO:

Least absolute shrinkage and selection operator

MELD score:

Model for end-stage liver disease score

NSBB:

Non-selective beta blocker

RBC:

Red blood cells

ROC:

Receiver-operating characteristic curve

SBP:

Systolic blood pressure

TIPS:

Transjugular intrahepatic portosystemic shunt

VIF:

Variance inflation factor

References

  1. Al-Khatib SM, Stevenson WG, Ackerman MJ et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018;72(14):e91–e220.

    Article  PubMed  Google Scholar 

  2. Gralnek IM, Camus Duboc M, Garcia-Pagan JC et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022;54(11):1094–1120.

    Article  PubMed  Google Scholar 

  3. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. New Engl J Med 2010;362(9):823–832.

    Article  CAS  PubMed  Google Scholar 

  4. Bosch J, García-Pagán JC. Prevention of variceal rebleeding. Lancet (London, England) 2003;361(9361):952–954.

    Article  PubMed  Google Scholar 

  5. Onofrio FQ, Pereira-Lima JC, Valença FM, Azeredo-da-Silva ALF, Tetelbom Stein A. Efficacy of endoscopic treatments for acute esophageal variceal bleeding in cirrhotic patients: systematic review and meta-analysis. Endosc Int Open 2019;7(11):e1503–e1514.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Plaz Torres MC, Best LM, Freeman SC et al. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2021;3(3):Cd0131122.

    Google Scholar 

  7. Veldhuijzen van Zanten D, Buganza E, Abraldes JG. The role of hepatic venous pressure gradient in the management of cirrhosis. Clin Liver Dis 2021;25(2):327–343.

    Article  PubMed  Google Scholar 

  8. Fortune BE, Garcia-Tsao G, Ciarleglio M et al. Child-Turcotte-Pugh class is best at stratifying risk in variceal hemorrhage: analysis of a US multicenter prospective study. J Clin Gastroenterol 2017;51(5):446–453.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Reverter E, Tandon P, Augustin S et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 2014;146(2):412-419.e413.

    Article  PubMed  Google Scholar 

  10. Toyoda H, Johnson PJ. The ALBI score: From liver function in patients with HCC to a general measure of liver function. JHEP Rep 2022;4(10):100557.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Chang CJ, Hou MC, Liao WC et al. Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma. J Gastroenterol 2012;47(5):531–539.

    Article  PubMed  Google Scholar 

  12. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology (Baltimore, MD) 2007;45(3):797–805.

    Article  PubMed  Google Scholar 

  13. Henry Z, Patel K, Patton H, Saad W. AGA clinical practice update on management of bleeding gastric varices: expert review. Clin Gastroenterol Hepatol 2021;19(6):1098-1107.e1091.

    Article  PubMed  Google Scholar 

  14. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology (Baltimore, MD) 2017;65(1):310–335.

    Article  PubMed  Google Scholar 

  15. Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 2007;26(30):5512–5528.

    Article  PubMed  Google Scholar 

  16. de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63(3):743–752.

    Article  PubMed  Google Scholar 

  17. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53(4):762–768.

    Article  PubMed  Google Scholar 

  18. Amitrano L, Guardascione MA, Bennato R, Manguso F, Balzano A. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol 2005;42(6):820–825.

    Article  PubMed  Google Scholar 

  19. Dmico G, Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Bailliere’s Clin Gastroenterol 1997;11(2):243–256.

    Article  Google Scholar 

  20. Wang MT, Liu T, Ma XQ, He J. Prognostic factors associated with rebleeding in cirrhotic inpatients complicated with esophageal variceal bleeding. Chin Med J 2011;124(10):1493–1497.

    PubMed  Google Scholar 

  21. Augustin S, Altamirano J, González A et al. Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding. Am J Gastroenterol 2011;106(10):1787–1795.

    Article  CAS  PubMed  Google Scholar 

  22. Seo YS. Prevention and management of gastroesophageal varices. Clin Mol Hepatol 2018;24(1):20–42.

    Article  PubMed  Google Scholar 

  23. Qureshi W, Adler DG, Davila R et al. ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastroint Endosc 2005;62(5):651–655.

    Article  Google Scholar 

  24. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology (Baltimore, MD) 2001;33(5):1060–1064.

    Article  CAS  PubMed  Google Scholar 

  25. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988;95(2):434–440.

    Article  CAS  PubMed  Google Scholar 

  26. Bambha K, Kim WR, Pedersen R et al. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 2008;57(6):814–820.

    Article  CAS  PubMed  Google Scholar 

  27. Lee YR, Park SY, Tak WY. Treatment outcomes and prognostic factors of acute variceal bleeding in patients with hepatocellular carcinoma. Gut Liver 2020;14(4):500–508.

    Article  PubMed  Google Scholar 

  28. Abraldes JG, Villanueva C, Bañares R et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008;48(2):229–236.

    Article  PubMed  Google Scholar 

  29. Zou D, Qi X, Zhu C et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: a retrospective study. Turk J Gastroenterol 2016;27(2):180–186.

    Article  PubMed  Google Scholar 

  30. Miyamoto Y, Enomoto H, Nishikawa H et al. Association of the modified ALBI grade with endoscopic findings of gastroesophageal varices. In vivo (Athens, Greece) 2021;35(2):1163–1168.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank our colleagues from the Department of Gastroenterology and Endoscopy Center for their strong support and cooperation in this experiment.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

DYQ, XHY, ZZH, ZG contributed to the study idea and design, drafting of the manuscript, and data analysis; CHY and DYQ were involved in data collection; ZZH and XSY contributed to critical revision of the manuscript; All authors approved the final manuscript for submission.

Corresponding author

Correspondence to Shiyong Xiao.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest regarding the publication of this article.

Ethical approval

This study was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University. The study adhered to the ethical principles outlined in the Declaration of Helsinki. Considering the retrospective nature of this study, the ethics committee waived the requirement for informed consent. Furthermore, all sensitive patient information underwent a process of anonymization and deidentification prior to analysis.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Figure S1. Correlation heatmap of predicted variables.

Abbreviations: ALBI score: Albumin-Bilirubin score; ALT: alanine aminotransferase; AST: aspartate aminotransferase; CKD: chronic kidney disease; Cr: creatinine; HCC: hepatocellular carcinoma; HE: hepatic encephalopathy; HR: heart rate; INR: international normalized ratio; MELD score: model for end-stage liver disease score; NET: non-endoscopic treatment; RBC: red blood cells; SBP: systolic blood pressure; WN: white nipple sign or overlying clot. (TIFF 774 kb)

Figure S2. (A) ROC curves for nomogram and other models; (B) Decision curves for nomogram and other models.

Abbreviations: ALBI score: Albumin-Bilirubin score; AUC: area under the ROC curve; CTP score: Child Turcotte Pugh score; ROC: receiver-operating characteristic curve; MELD score: model for end-stage liver disease score. (JPG 201 kb)

Table S1. univariate and multivariate logistic regression analysis of the selected variables.

Abbreviations: CI: confidence interval; HCC: hepatocellular carcinoma; INR: international normalized ratio; OR: odds ratio. (XLSX 10 kb)

Table S2. The VIF of independent predictors included in the nomogram.

Abbreviations: HCC: hepatocellular carcinoma; INR: international normalized ratio; VIF: variance inflation factor. (XLSX 10 kb)

Table S3. The TRIPOD Checklist of the study.

(DOCX 25 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, Y., Xu, H., Zhang, Z. et al. A Novel Nomogram for Predicting Early Rebleeding After Endoscopic Treatment of Esophagogastric Variceal Hemorrhage. Dig Dis Sci (2024). https://doi.org/10.1007/s10620-024-08382-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10620-024-08382-0

Keywords

Navigation